These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Biological therapy as treatment of inflammatory bowel diseases].
    Author: Agnholt J.
    Journal: Ugeskr Laeger; 2008 Jun 09; 170(24):2152-6. PubMed ID: 18565302.
    Abstract:
    Biological therapy as treatment of inflammatory bowel diseases has been one of the major achievements since the introduction of steroids. Infliximab has been approved for the treatment of Crohn's disease and ulcerative colitis, and adalimumab for the treatment of Crohn's disease. Both treatments have documented effect for induction of clinical response and remission, and can be used to maintain remission. However, it is important to define the treatment goals before initiation, and whether biologicals should be used alone or together with immunosuppressants as azathioprine.
    [Abstract] [Full Text] [Related] [New Search]